Ying Z, Xie Y, Zheng W, Liu W, et al. Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial. Bone Marrow Transplant 2022 Dec 7. doi: 10.1038/s41409-022-01888.
PMID: 36477110